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Abstract
Discussion concerning Calorie Restriction (CR) and low carbohydrate diet (LCD) has continued for years. Authors
have developed research of LCD using super LCD with 12% of carbohydrate. The biology of human aging includes
study between human and mammalian such as mice, rhesus monkeys. Moderate CR reduced age-related mortality,
incidence of diabetes, cancer, cardiovascular disease. By very low calorie diet (VLCD), body weight can be reduced,
but the diabetic pathological state remains. Besides CR and LCD, Zone, Ornish, LEARN Diets and Mediterranean
style can be applicable. There are very low-carbohydrate ketogenic diet (VLCKD), Moderate-LCD, High-
Carbohydrate Diet, as related with the definition of LCD. Morbus (M) value was investigated for clinical practice of
LCD, in which M value was remarkably improved by LCD treatment.
Keywords: Low carbohydrate diet (LCD); Morbus value (M value);
Type 2 diabetes mellitus (T2DM); Calorie restriction (CR); Anti-aging
medicine
Abbreviations: LCD: Low-Carbohydrate Diet; CR: Calorie-
Restricted; T2DM: Type 2 Diabetes Mellitus; M Value: Morbus Value;
MAGE: Mean Amplitude of Glycemic Excursions; VLCD: Very Low
Calorie Diet; ADA: American Diabetes Association; VLCKD: Very
Low-Carbohydrate Ketogenic Diet
Introduction
Regarding nutritional therapy for metabolic and diabetic patients,
the discussion has been continued for long concerning Calorie
Restriction (CR) and low carbohydrate diet (LCD). Several
investigators recently revealed the predominant efficacy of LCD
compared with CR [1-3]. In western countries, Bernstein and Atkins
originally launched LCD [4,5], which was effective and striking
treatment at that time. After that, LCD has been more prevalent with
the several efficacy in clinical practice [6-8].
On contrast, in Japan, authors and colleagues have started LCD and
developed clinical research related with LCD [9,10]. We reported the
significant role of ketone bodies in LCD and in physiological role of
pregnant female and fetus-newborn axis [11]. We also continued
medical and social development of LCD through Japan LCD
promotion association, we proposed 3 types of actual LCD meal in
daily life, which are petit, standard and super LCD [12].
Biology of Human and Animals in CR
The biology of human aging includes several investigation for
anatomical, physiological and clinical similarities between human and
other experimental materials and animals. They include yeast, worms,
flies, mice, dogs, pigs, monkeys, and so on. Especially, some kinds of
mammalian are recommended for its similarity with human.
Anti-aging medicine investigates and searches for speed against
aging. From this viewpoint, discussion was found for years as to
whether the lifespan is extended or the aging is delayed by CR. Among
them, there are famous reports of rhesus monkeys over 20 years [13].
As a result, moderate CR reduced age-related mortality. In
particular, CR reduced the incidence of diabetes, cancer,
cardiovascular disease and cerebral atrophy. In comparison with
control and CR group, the incidences of both neoplasia and
cardiovascular disease was reduced by 50%. Especially, improvement
in insulin sensitivity conferred by CR, has been consistent and
remarkable [14,15]. Improved glucose homeostasis was maintained,
inducing that diabetes was prevented by CR. Out of 38 control
monkeys, 5 diabetes and 11 pre-diabetics were observed. In contrast,
all animals on CR group revealed no glucose impairment. From these
data, CR would possibly make aging slower in a primate species.
Humans are classified in the category of primates. Therefore, in
medical research, it is expected that the results and information
obtained by monkeys will be found in man as well. From the viewpoint
of molecular biology, is that true in all cases? Lots of research have
found concerning several experimental animals.
Transcriptional patterns of CR-animals suggest that CR retards the
aging process by causing a metabolic shift toward increased protein
turnover and decreased macromolecular damage [16]. The increase in
longevity by dietary CR is coupled to profound beneficial effects on
age-related pathology [17]. There is the reverse relationship between
calorie intake and increase of lifespan in mice, suggesting a role for
regulators of energy metabolism in the mechanism of CR.
Consequently, metabolic reprogramming by induction of CR may be a
crucial point in the mechanism for the extension of life span [13].
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role for nutrient which is responsive signaling molecules including
SIRT1, mTOR and PGC-1α in aging and CR [18]. How are these
findings related to the aging mechanism? The conservation of the
effects of CR would depend on aging in primates.
Based on the above circumstances, attention was paid to whether
the effects in monkeys could be seen in humans as well. A multicenter
study involving 16 large facilities in the United States was conducted.
Look AHEAD Research Group reported the results of multicenter
study [19]. They included 5145 overweight or obese patients with type
2 diabetes mellitus (T2DM) and followed up 13.5 years. As a result,
intensive lifestyle intervention focusing on weight loss did not reduce
the rate of cardiovascular events.
Furthermore, the negative effect on musculoskeletal system [20]
suggested in rhesus monkeys has also been confirmed in humans [21].
From the above, it is time to need a scientific re-evaluation on the
effectiveness and safety of CR.
CR and VLCD
There was an impressive report showing the effectiveness and limit
of Very Low Calorie Diet (VLCD) [22,23]. It shows the results of first 6
months from the Newcastle University to the British Diabetes
Association Institute magazine [22] and several years' data [23] to the
American Diabetes Association Diabetes Care. The protocol of the
study is a long-term study in which 15 patients with type 2 diabetes
carry VLCD for 2 months and CR for 6 months. Optifast® 624 kcal/day
(PFC=34:19.5:43) was used for VLCD and then gradually increased the
caloric intake. The judgment of remission of diabetes was less than 126
mg/dL of fasting blood glucose [22,23]. As a result of short-term vs
long-term patients, body weight change and remission rate were of
99.0 → 84.5 kg, vs 96.9 → 83.0 kg, 86.7% vs 50.0%, respectively. In the
latter, the fasting blood glucose did not decrease enough.
This study seems to suggest implications for diabetic diet therapy in
the future. American Diabetes Association (ADA) previously
mentioned the optimization of calorie as the most important task,
because its aim was to acquire ideal weight [24]. In the countries where
T2DM develops after obesity such as United States, eliminating obesity
could be thought to decrease T2DM. Meanwhile, ADA stated in 2004
that CR diet cannot be maintained for a long time [25], and
monitoring glucose intake has now become regarded as an important
issue [26,27].
By this study, weight loss effect of VLCD became clear. However,
even if the weight improves, the pathological diabetic state remains.
Although visceral fat area drastically decreases and hepatic insulin
resistance improves, elevated blood glucose persists. One of the cause
is the continuation of intake for carbohydrates. Furthermore, it is not
easy to actually live 8 weeks with a meal less than 700 Kcal a day. From
the above, it would be rather difficult to aim for standard weight in
application of CR.
Progress in LCD
After Atkins an Bernstein started LCD [4,5], several impressive
research were reported. Atkins, Zone, Ornish and LEARN Diets were
compared as well-known four dietary regimens [28]. Similary, Atkins,
South Beach, Weight Watchers and Zone diets were also compared
[29]. After that, Dietary Intervention Randomized Controlled Trial
(DIRECT) group reported the efficacy of the LCD up to 2 years [6],
and up to 6 year [7]. The effect of LCD plus Mediterranean-style diet
was introduced with efficacy [30], which might be one of the better
option in the future.
Formerly, the definition of LCD was rather vague. The effect of LCD
over the years has been summarized, according to the percentage of
carbohydrates [31,32]. Suggested definitions for different forms of
LCD are shown in Table 1, which are very low-carbohydrate ketogenic
diet (VLCKD), LCD, Moderate-LCD, High-Carbohydrate Diet [31-33].
Very low-carbohydrate ketogenic diet (VLCKD)
Carbohydrate, 20-50 g/day or <10% of the 2000 kcal/d diet, whether or not ketosis occurs. Derived from levels of carbohydrate required to induce ketosis in most
people.
Recommended early phase (“induction”) of popular diets such as Atkins Diet or Protein Power.
Low-carbohydrate diet: <130 g/day or <26% total energy
The ADA definition of 130 g/day as its recommended minimum.
Moderate-Carbohydrate Diet: 26%-45%
Upper limit, approximate carbohydrate intake before the obesity epidemic (43%).
High-Carbohydrate Diet: >45%
Recommended target on ADA websites.
The 2010 Dietary Guidelines for Americans recommends 45%-65% carbohydrate. The average American diet is estimated to be w49% carbohydrate.
Carbohydrate Consumption (NHANES).
Table 1: Suggested definitions for different Forms of low-carbohydrate diets [31-33]. (ADA: American Diabetes Association; NHANES: National
Health and Nutrition Examination Survey; NHANES is a series of studies conducted since 1960 that monitors >5000 people. The content of this
table is from some reports).
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JAMA published the US dietary guidelines (the 2015 US dietary
guidelines) [34]. In the guideline, an accurate revision of the Dietary
Guidelines is crucial to the health of millions of people. Integral to this
process is the Dietary Guidelines Advisory Committee (DGAC) report.
Research in LCD
In Japan, there are long history of CR and recent LCD treatment,
because rice is our staple food for long years. Then, we can treat
diabetic patients for CR or LCD and compare the treatment of in-
patients and also out-patients.
Indeed, we have experienced many cases that blood glucose control
improves with calorie restriction. However, its successful reason is that
the disease duration is short and CR improves pancreatic first phase
insulin secretion. Since active exercise therapy is also carried out in
education hospitalization, insulin sensitivity of muscles will be
improved even more [35]. On the other hand, patients with long
duration would not have so effective results in CR treatment.
Furthermore, in the case of Japanese early diabetics, the mean BMI
at onset is 24.4 and there are not many cases of obesity combined [36].
For even Japanese diabetics in early stages, will CR diets be really the
first choice? Instead, LCD seems to be recommended because blood
glucose would not be so increased.
The process for LCD development until now in Japan would be
summarized as follows. The authors and collaborators launched the
LCD [9,10] and NIPPON DATA 80 (National Integrated Project for
Prospective observation of Non-communicable Disease and its Trends
in the Aged 1980) reported 29 year data concerning the effect of LCD
[37]. A research on RCT for mild restriction of glucose 130 g/day was
reported [38]. Furthermore, we reported research of LCD with
hypertriglyceridemia [39], with hyperketonemia in the axis of fetus-
placenta-newborn-pregnant women [11], with renal function [40],
with lifestyle habits [41], and so on.
In addition, super-LCD with 12% of carbohydrate has reduced
blood glucose and M value in short period [39,40,42]. Morbus (M)
value is the index which represents both blood sugar level and mean
amplitude of glycemic excursions (MAGE) [43,44].
M value is calculated by the following formula: M=MBS+MW,
where MW=(maximum blood glucose-minimum glucose)/20;
MBS=The mean of MBSBS; MBSBS=Individual M-value for each
blood glucose value calculated as (absolute value of (10×log(blood
glucose value/120)))3.
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Regarding glucose variability, daily profiles of blood glucose has
been measured 7 times a day, which data were calculated into average
glucose and M value. Similar results were found on 7 times or 20 times
of sampling per day [45,46]. It also revealed similar results compared
with the continuous glucose monitoring (CGM) [47,48].
Daily profile of blood glucose and M value were investigated in 2
patients with T2DM [39,40,42] (Figure1).
The protocol was measuring glucose on day 0, 2, 12 from the start of
LCD. There were remarkable decrease in glucose and M value by LCD
[39,40,42].
Figure 1: The profile of blood glucose and M value.
Conclusion
In summary, research on human and animal biology has continued
for years. Among them, research on anti-aging medicine from gene
expression to clinical practice has been remarkable for extension of life
span. In fact, the importance of nutrition is becoming apparent, and it
seems to be useful for improving people's health and lifespan.
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